C-J Advisory’s AstraZeneca AZN Stock Holding History

C-J Advisory’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-175	Closed	-$16K	–	57
2019 Q3	$16K	Buy	+175	New	+$15.2K	0.01%	112

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

C-J Advisory's AZN Position: Q4 2019 in Review

C-J Advisory sold out of AstraZeneca (AZN) in Q4 2019, closing a stake of 175 shares — an estimated $16K sold.

C-J Advisory first reported a position in AZN in Q3 2019 and held it in 1 quarter. The position peaked at $16K in Q3 2019. 633 funds tracked by Wall St. Rank hold AZN as of Q4 2019.

C-J Advisory reported no remaining AstraZeneca position as of Q4 2019 after selling out during the quarter.
C-J Advisory sold 175 AstraZeneca shares in Q4 2019, an estimated $16K.
C-J Advisory first reported a position in AstraZeneca in Q3 2019 and held it in 1 quarter.
C-J Advisory's AstraZeneca position peaked at $16K in Q3 2019.
633 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2019.

Based on C-J Advisory's 13F filing for Q4 2019, filed 10 Feb 2020.